Sign inJoin waitlistJoin the waitlist

Demetrius Lopes

Leads the Advocate Brain & Spine Institute's Neuroendovascular Program

Credentials: · · · · · ·

History

Wake Forest University School of Medicine · Wake Forest University Baptist Medical Center
Present

State University of New York at Buffalo
2000–2001
Neurological Surgery
University at Buffalo School of Medicine
1993–2000
Neurology
Indiana University School of Medicine
1994–1997
University of Illinois College of Medicine at Chicago
1993–1994
Federal University Of Rio Grande Do Sul, MD
1989–1993

Research

Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct
New England Journal of Medicine · 2018 · 4,383 citations
Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke
New England Journal of Medicine · 2015 · 4,130 citations
Pipeline for uncoilable or failed aneurysms: results from a multicenter clinical trial
Radiology · 2013 · 942 citations

RH
Ricardo Hanel
46 papers · 1 as a resident
Adnan Siddiqui
42 papers
Elad Levy
32 papers · 1 as a fellow
KK
Kiffon Keigher
22 papers
Roham Moftakhar
21 papers
Lee Tan
20 papers · 20 as a resident
Peter Kan
20 papers
Giuseppe Lanzino
19 papers · 5 as a resident
Krishna Joshi
19 papers · 19 as a resident
LH
Leo Hopkins
19 papers
Raul Nogueira
19 papers
AP
Ajit Puri
17 papers

Clinical trials

The Use of p48/64 MW HPC Flow Modulation Device in the Treatment of Wide-necked Intracranial Aneurysms
Principal investigator · Recruiting
phenox Inc.
2026–2032
US IDE Study of the Contour NEurovasCular System™ for IntraCranial Aneurysm Repair
Principal investigator · Active not recruiting · Phase 4
Cerus Endovascular, Inc.
2021–2030
Pipeline™ Vantage Embolization Device With Shield Technology™ for Wide-Necked Intracranial Aneurysms (ADVANCE)
Principal investigator · Terminated
Medtronic Neurovascular Clinical Affairs
2020–2023
Contour Neurovascular System™ ContiNued Access Investigational Device EXempTion (IDE) Trial (NEXT Trial)
Site PI · Recruiting
Cerus Endovascular, Inc.
2025–2030